Tickers

1. Composite Trajectory Verdict

Given ARCB's capital-intensive Asset-Based segment and working-capital-dependent Asset-Light segment, all three financial statements carry roughly equal weight for assessing performance.

Composite Trajectory: Deteriorating

Annual results show consistent deterioration across the income statement (revenue down 4.0% YoY in 2025, operating income down 63%, net income down 65%), cash flow statement (operating cash flow fell from $322.2M in 2023 to $229.0M in 2025), and balance sheet (equity declined from $1.314B to $1.296B while total debt rose from $189.1M to $223.9M). The most recent quarter (Q2 2026) shows revenue growth (+15.9% YoY) but a swing to operating loss (-$20.6M vs +$37.3M) driven by $85.3M in asset impairment charges, reinforcing the downward trend.

2. Red Flags

• Recurring large impairment charges: 2025 included $12.0M impairment (Panther trade name $6.6M, Vaux assets $5.4M); Q2 2026 added $85.3M (Vaux Freight Movement System $50.8M, Panther trade name $25.7M) (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A).
• Contingent earnout gains flattered prior earnings: 2024 operating income benefited from a $90.3M pre-tax gain from earnout remeasurement; 2025 benefit was only $2.7M; liability reduced to zero in 2025 (10-K 2025-12-31, MD&A Consolidated Results).
• Goodwill at risk: $304.8M of goodwill resides in the Asset-Light segment; MD&A warns that "significant declines... could result in impairment and a resulting noncash write-off of a significant portion of the goodwill" (10-K 2025-12-31, MD&A Current Economic Conditions).
• Operating cash flow declining annually: $322.2M (2023) → $285.8M (2024) → $229.0M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Leverage rising while cash falls: Total debt (including current portion) increased from $189.1M to $223.9M; cash and short-term investments fell from $157.2M to $124.2M (10-K 2025-12-31, Consolidated Balance Sheets; Note G).
• Equity erosion: Stockholders' equity dropped from $1.314B to $1.296B despite net income, due to $75.6M share repurchases and $11.0M dividends in 2025 (10-K 2025-12-31, Consolidated Statements of Stockholders’ Equity).
• Deferred tax liability surge: Net deferred tax liabilities jumped from $69.1M to $102.3M due to the One Big Beautiful Bill Act's 100% expensing provision (10-K 2025-12-31, MD&A Income Taxes).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Annual GAAP results deteriorated across the three-year period: consolidated revenue fell from $4.427B (2023) to $4.179B (2024) to $4.010B (2025); operating income dropped from $172.6M to $244.4M to $90.3M; net income declined from $195.4M to $174.0M to $60.1M; diluted EPS fell from $7.93 to $7.30 to $2.62 (10-K 2025-12-31, Consolidated Statements of Operations). Asset-Light segment swung from a $58.4M operating profit in 2024 to a $15.3M loss in 2025. Quarterly Q2 2026 showed revenue growth (+15.9% YoY to $1.185B) but an operating loss of $20.6M vs $37.3M profit in Q2 2025, primarily due to $85.3M impairment charges (10-Q 2026-06-30, MD&A Consolidated Results). Six-month figures show similar pattern: revenue up 9.8% but operating loss of $17.2M vs $43.9M profit (10-Q 2026-06-30, MD&A Consolidated Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow has declined each year: $322.2M (2023) → $285.8M (2024) → $229.0M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capex net of financings) was $103.1M (2023), $62.7M (2024), and $114.2M (2025) — an improvement in 2025 versus 2024 but still below 2023. Investing outflows remained substantial due to capital expenditures ($232.6M gross in 2025, $303.8M in 2024). Financing activities consistently used cash ($196.6M, $233.3M, $177.7M) for debt repayment, share repurchases, and dividends. Quarterly cash flow statements for Q2 2026 are not provided in the filings.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Comparing year-end 2024 to 2025: total assets roughly flat ($2.430B → $2.453B), but composition weakened. Cash and short-term investments fell from $157.2M to $124.2M; accounts receivable declined from $394.8M to $371.0M. Property, plant & equipment net rose from $1.066B to $1.143B due to service center remodels and equipment purchases. Intangible assets net dropped from $88.6M to $69.4M after the Panther trade name impairment. Total debt (notes payable) increased from $189.1M to $223.9M; operating lease liabilities rose from $224.3M to $240.7M. Stockholders' equity declined from $1.314B to $1.296M despite $60.1M net income, as $75.6M was spent on share repurchases and $11.0M on dividends (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Stockholders’ Equity; Note G; Note F).

6. Data Gaps

• Quarterly cash flow statements for Q2 2026 and Q2 2025 (10-Q 2026-06-30 truncated).
• Quarterly balance sheets for Q1 2026, Q3 2025, and Q2 2025 (10-Qs for 2026-03-31, 2025-09-30, 2025-06-30 not provided).
• Full-year 2023 balance sheet (10-K only shows 2024 and 2025).
• Segment-level quarterly operating statistics (tonnage, shipments, revenue per hundredweight) for 2026 quarters.
• Detailed breakdown of Q2 2026 restructuring charges beyond the $2.2M mentioned in MD&A.